Tim Connor’s Post

Eucalyptus has signed an agreement to be acquired by hims & hers. When the deal closes, we plan to build the best consumer health business in the world. I'll oversee the company’s international business. I think back to the launch of Hims & Hers as really the beginning of the patient-led transformation that healthcare has been undergoing for the last decade. Seeing a website that felt aspirational, low friction, clearly explained - with a payment model that was approachable - felt revolutionary at a time when the US healthcare system was everything but that. When we were launching Eucalyptus, we drew inspiration from Hims & Hers. So this feels full circle. As we look forward, this patients-first era of healthcare is only accelerating. It's become abundantly clear that in the future, patients will have a relationship with one or many digital clinics where they understand their own health data through regular tracking and diagnostics, use that information to interact with a variety of practitioners, and then take action across a wide range of their healthcare decisions. Hims & Hers is the best-positioned business in the world to be the home for consumer health. They've set the bar for what it means to be focused on the patient for the last decade — and as we accelerate toward the future, being part of what is fast becoming the leading global consumer health platform is extremely exciting. Of course, this is also a moment to look backward and say thank you - to our investors, staff, clinicians, partners and our patients. Eucalyptus started seven years ago as a bet that generalist talent from Australia could build a globally competitive consumer healthcare business. In many ways, this is the achievement of that aspiration. And as we look forward, our team now has the opportunity to be part of building one of the great healthcare businesses in the world — one that transforms hundreds of millions of lives.